Study guide

11.5 Over-the-Counter, Alternative & Complementary Therapies

Certified Asthma Educator AE-C

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Exam Overview

1.1 About the AE-C Examination 1.2 How to Use This Study Guide

2 Chapter 2: Anatomy, Physiology & Airway Pathophysiology

2.1 Normal vs. Asthmatic Airway Architecture 2.2 Cellular Inflammation, Mediators & Airway Remodeling 2.3 Bronchial Hyperresponsiveness & Airflow Obstruction Mechanics

3 Chapter 3: Triggers, Exposures & Phenotypes

3.1 Aeroallergens & Allergic Sensitization Mechanisms 3.2 Non-Allergic Irritants & Environmental Airborne Hazards 3.3 Respiratory Infections, Exercise & Physiological Stressors 3.4 Asthma Phenotypes, Endotypes & Lifespan Variations 3.5 Genetics, Family History & Early-Life Determinants

4 Chapter 4: Comorbidities, Medications & Asthma Mimics

4.1 Upper Airway Diseases & Gastroesophageal Reflux 4.2 Systemic Comorbidities, Obesity & Adverse Drug Reactions 4.3 Differential Diagnosis & Major Asthma Mimics

5 Chapter 5: Clinical History & Physical Assessment

5.1 Comprehensive Asthma History & Risk Stratification 5.2 Physical Examination, Auscultation & Atopic Stigmata 5.3 Acute Exacerbation Severity Triage & Life-Threatening Red Flags 5.4 Criteria for Specialist Referral & Advanced Consultation 5.5 Medication Reconciliation & Integrating the Medical Record

6 Chapter 6: Diagnostic Testing & Pulmonary Function

6.1 Spirometry Principles, Maneuvers & ATS/ERS Quality Criteria 6.2 Bronchodilator Reversibility Testing Protocols & Interpretation 6.3 Peak Expiratory Flow Monitoring & Personal Best Determination 6.4 FeNO, Methacholine Challenge & Allergy Testing Modalities

7 Chapter 7: Severity, Control & Psychosocial Evaluation

7.1 Asthma Severity Classification (NHLBI EPR-3 & GINA) 7.2 Asthma Control Assessment Tools & Validated Questionnaires 7.3 Health Literacy, Educational Needs Assessment & Plain Language Principles 7.4 Psychosocial, Cultural & Family Dynamics in Self-Management

8 Chapter 8: Reliever Medications & Bronchodilators

8.1 Short-Acting Beta-2 Agonists (SABAs) & Cellular Mechanisms 8.2 SABA Overuse, Paradoxical Hyperresponsiveness & Safety Warnings 8.3 Short-Acting Muscarinic Antagonists (SAMAs) & Acute Adjunctive Therapy 8.4 SMART/MART & Anti-Inflammatory Reliever (AIR) Regimens

9 Chapter 9: Inhaled Corticosteroids & Combination Therapies

9.1 Inhaled Corticosteroids: Pharmacology, Potency & Dosing 9.2 ICS Adverse Effects, Systemic Safety & Dispelling Steroid Phobia 9.3 Long-Acting Beta-2 Agonists & Fixed-Dose Combination Inhalers 9.4 Stepwise Pharmacotherapy Guidelines (Age-Stratified Step-Up & Step-Down)

10 Chapter 10: Additional Controllers & Biologic Therapies

10.1 Leukotriene Modifiers & 5-Lipoxygenase Inhibitors 10.2 Long-Acting Muscarinic Antagonists (LAMAs) & Alternative Controllers 10.3 Monoclonal Antibodies & Biologic Therapies for Severe Asthma 10.4 Systemic Corticosteroids, Adrenal Safety & Immunizations 10.5 Allergen Immunotherapy, Intranasal Therapy & Treating Comorbidities

11 Chapter 11: Inhalation Devices & Delivery Mechanics

11.1 Pressurized Metered-Dose Inhalers (pMDIs) & Valved Holding Chambers 11.2 Dry Powder Inhalers (DPIs): Mechanics, Resistance & Technique 11.3 Soft Mist Inhalers (SMIs) & Small-Volume Nebulizers (SVNs) 11.4 Device Selection Algorithm, Patient Capabilities & Technique Assessment 11.5 Over-the-Counter, Alternative & Complementary Therapies

12 Chapter 12: Environmental Control & Behavioral Interventions

12.1 Evidence-Based Indoor Allergen Mitigation & Integrated Pest Management 12.2 Tobacco Cessation, Electronic Nicotine Systems & Irritant Elimination 12.3 Exercise-Induced Bronchoconstriction (EIB) Management & Sports Participation 12.4 Behavioral Counseling, Motivational Interviewing & Adherence Enhancement 12.5 Social, Economic & Substance-Use Barriers to Self-Management

13 Chapter 13: Action Plans, Exacerbations & Continuing Care

13.1 Written Asthma Action Plans & the Traffic-Light Zone System 13.2 School, Workplace & Childcare Action Plans 13.3 Home & Outpatient Acute Exacerbation Protocols 13.4 Periodic Reevaluation, Step-Down & Post-Discharge Follow-Up 13.5 Designing the Individualized Self-Management Education Plan 13.6 Coaching Decision-Making, Confidence & Documenting Mastery

14 Chapter 14: Program Needs Assessment & Implementation

14.1 Epidemiological Analysis & Community Needs Assessment 14.2 Evidence-Based Asthma Interventions & CDC EXHALE Strategies 14.3 Program Design, Multidisciplinary Staffing & Operational Workflows

15 Chapter 15: Evaluation, Ethics, Quality & Health Systems

15.1 Legal, Ethical, HIPAA/FERPA & Clinical Documentation Standards 15.2 Program Evaluation, CQI Methodologies & Outcome Metrics 15.3 Interprofessional Partnerships, Advocacy & Reimbursement Pathways

11.5 Over-the-Counter, Alternative & Complementary Therapies

Key Takeaways Explain This Topic AI

Over-the-counter epinephrine inhalers relieve bronchospasm briefly but treat none of the underlying inflammation, and their availability lets patients postpone the controller therapy and medical evaluation that actually prevent death.

Non-selective adrenergic agents such as epinephrine and ephedrine stimulate alpha and beta-1 receptors as well as beta-2, producing tremor, palpitations, tachycardia, and blood-pressure elevation that selective albuterol largely avoids.

Roughly one in three to one in two adults with asthma uses some complementary therapy, and most never disclose it unless asked directly and without judgment.

Breathing retraining techniques can improve symptoms and quality-of-life scores but do not improve lung function or airway inflammation, so they are adjuncts and never replacements for controller therapy.

Herbal and supplement products are not subject to pre-market potency or purity verification, and some have been found adulterated with undeclared corticosteroids or sympathomimetics.

Last updated: September 2026

11.5 Over-the-Counter, Alternative & Complementary Therapies

Quick Answer: Over-the-counter asthma products are short-acting bronchodilators with no anti-inflammatory activity , and they are dangerous less because of direct toxicity than because they let a patient with worsening inflammation feel temporarily better while postponing controller therapy and medical evaluation. Complementary therapy use is common and under-disclosed; the educator's job is to ask without judgment, document, screen for interactions, and redirect toward therapy that prevents exacerbations — not to lecture.

Over-the-Counter Bronchodilators

The United States is unusual in permitting non-prescription inhaled bronchodilators for asthma. Candidates must be able to explain why these products are pharmacologically inferior.

  • Feature OTC epinephrine inhaler Prescription albuterol (SABA)
  • Receptor selectivity Non-selective: alpha, beta-1, and beta-2 Relatively beta-2 selective
  • Typical duration Short — roughly 1 to 3 hours 4 to 6 hours

Cardiovascular effects Tachycardia, palpitations, tremor, blood-pressure elevation from alpha and beta-1 activity Tremor and mild tachycardia; substantially less cardiovascular stimulation

Anti-inflammatory activity None None

Dosing supervision None — no prescriber sees the patient Prescriber, dose counter, and refill record create a monitoring trail

Oral over-the-counter products containing ephedrine (marketed for bronchial asthma, sometimes combined with guaifenesin) share the same non-selective profile with additional systemic exposure and are also not recommended in asthma guidelines.

  • Why Availability Is the Real Hazard Worsening airway inflammation
  • │
  • ▼
  • Symptoms increase ──► Patient buys OTC inhaler ──► Symptoms briefly relieved
  • │ │
  • │ ▼
  • │ No prescriber contact, no controller,
  • │ no action plan, no refill trail
  • ▼ │
  • Inflammation continues unopposed ◄─────────────────────────┘
  • │
  • ▼
  • Severe exacerbation presenting late, often after days of escalating self-treatment

The refill record that flags a patient using three or more SABA canisters a year simply does not exist for cash purchases at a pharmacy counter. A patient can consume an entire season of rescue therapy invisibly.

Counseling script: "That inhaler does relax the muscle around your airways for an hour or two, so it isn't imaginary relief. What it can't do is calm the swelling that's causing the squeeze in the first place — and because nobody sees how often you're buying it, nobody knows your asthma is slipping. Let's get you something that treats the swelling and a plan that tells you when the squeeze means you need help."

Complementary and Alternative Therapies

Surveys consistently find that a large minority to roughly half of adults with asthma use some complementary approach, and disclosure rates are low — frequently because patients expect criticism or believe "natural" products are not medications worth mentioning.

Approach What the evidence shows Practical position

Breathing retraining (Buteyko, Papworth, yoga breathing) Can improve symptom scores, reliever use, and quality of life; does not improve lung function or airway inflammation Reasonable adjunct for patients with dysfunctional breathing or anxiety; never a controller substitute

Vitamin D supplementation Trial results are mixed; some analyses suggest reduced exacerbations requiring oral corticosteroids among people who were deficient, but a randomized trial in vitamin-D-deficient children with asthma did not reduce exacerbations Correct documented deficiency; do not present supplementation as asthma therapy

Herbal preparations No herbal product has guideline-level evidence for asthma; potency and purity are unverified, and adulteration with undeclared corticosteroids or sympathomimetics has been documented Ask, document, screen for interactions

Acupuncture Trials show no consistent benefit on objective lung function Not recommended as asthma therapy; not dangerous if it does not displace treatment

  • Homeopathy No demonstrated benefit beyond placebo Actively harmful when it displaces controller therapy
  • Chiropractic manipulation No demonstrated effect on asthma outcomes Not asthma therapy

Caffeine Weak bronchodilator chemically related to theophylline Can modestly affect lung function testing; ask about intake before spirometry

Exam Trap: "Does not improve lung function" is not the same as "has no role." Breathing retraining is a legitimate adjunct precisely because many patients have coexisting dysfunctional breathing or anxiety driving symptom burden beyond their measured obstruction. The error is substitution, not use.

Eliciting Disclosure

A direct yes/no question produces a no. A normalized, specific, non-judgmental question produces the truth.

Ineffective: "You're not taking any herbal remedies, are you?"

Effective: "Lots of people with asthma use teas, supplements, breathing exercises, or things they buy at the pharmacy without a prescription — I'd like to know everything you're using so I can check nothing interacts. What have you tried?"

Then:

Document every product with name, dose, frequency, and source.

Screen for specific hazards — sympathomimetic-containing products, anything that could interact with theophylline or corticosteroids, and products used in place of controller therapy.

Affirm what is harmless. Dismissing a safe practice the patient values costs you the trust you need for the conversation that matters.

Redirect precisely. Name what the alternative cannot do — prevent airway inflammation and prevent exacerbations — rather than attacking the patient's choice.

Report any product that appears to be interacting with or displacing prescribed therapy to the prescribing clinician.

Emphasizing Prescribed Therapy Without Confrontation

The Detailed Content Outline asks the educator to "emphasize importance of taking medications as prescribed when alternative and over-the-counter medications are available." The technique that works is a role clarification , not a prohibition:

Patient's framing Educator's reframe

"The inhaler from the drugstore works just as well." "It opens the airway for an hour or two. It doesn't touch the swelling underneath, and that's what sends people to the emergency department."

"I only want natural treatments." "Let's keep what you're using if it's safe. I want to add the one medicine that's been shown to prevent attacks, and we can review how much you still need over time."

"Steroids are dangerous, so I use the herbal one." "The dose in your inhaler is measured in micrograms and stays mostly in the airway. Let's talk through exactly what side effects you're worried about."